Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Treatment Outcomes During Brivaracetam Treatment by Seizure Freedom Status at Baseline: Post hoc Analysis of a Real-world, US Study

              Author:Dave, Hina   French, Jacqueline A.   Henninger, Heidi   Altalib, Hamada Hamid   Porter, Roger   Gelfand, Michael   Martin, Melinda S.   Dongre, Prashant   Elmoufti, Sami   Schulz, Anne-Liv   Dimova, Svetlana   Sperling, Michael R.   

              Session Name:P14: Epilepsy/Clinical Neurophysiology (EEG): ASMs Clinical Trial 2  

              Topic:Epilepsy/Clinical Neurophysiology (EEG)  

              Program Number:P14.001  

              Author Institution:University of Texas Southwestern Medical Center, Dallas, TX  NYU Comprehensive Epilepsy Center, New York, NY  Maine Medical Center, Portland, ME  Yale School of Medicine, New Haven, CT  University of Pennsylvania, Philadelphia, PA  UCB Pharma, Smyrna, GA  UCB Pharma, Morrisville, NC  UCB Pharma, Monheim am Rhein, Germany  UCB Pharma, Brussels, Belgium  Thomas Jefferson University, Philadelphia, PA  

              Cognitive debrief of the Clinical Global Impression of Improvement for Nonseizure Symptoms measure in Dravet syndrome (DS) and Lennox–Gastaut syndrome (LGS): The Caregiver Perspective

              Author:Shah, Drishti   Andrews, Scott   Nacson, Alise   Symonds, Tara   Hughes, Sophie   Benitez, Arturo   Sams, Lara   

              Session Name:P14: Epilepsy/Clinical Neurophysiology (EEG): ASMs Clinical Trial 2  

              Topic:Epilepsy/Clinical Neurophysiology (EEG)  

              Program Number:P14.002  

              Author Institution:Takeda Pharmaceutical Company Limited, Cambridge, MA  Clinical Outcomes Solutions, Folkstone, United Kingdom  

              Efficacy, Safety, and Tolerability of Adjunctive Eslicarbazepine Acetate in Focal Seizure Patients With Focal to Bilateral Tonic-Clonic Seizures at Baseline

              Author:Chung, Steve   Guirguis, Samy   Cantu, David   Moreira, Joana   Magalhaes, Luis   Hall, Diane   Zhang, Yi   Grinnell, Todd   

              Session Name:P14: Epilepsy/Clinical Neurophysiology (EEG): ASMs Clinical Trial 2  

              Topic:Epilepsy/Clinical Neurophysiology (EEG)  

              Program Number:P14.003  

              Author Institution:Banner University Medical Center, Phoenix, AZ  Sunovion Pharmaceuticals Inc. , Beverly Hills, CA  Sunovion Pharmaceuticals Inc. , Fort Lee, NJ  Bial-Portela & C S.A., Coronado, Portugal  Bial-Portela & C S.A., Coronado (S. Romão e S. Mamede), Portugal  Sunovion Pharmaceuticals Inc. , Marlborough, MA  

              Long-term Safety and Efficacy of Add-on Cannabidiol (CBD) for Seizures Associated With Tuberous Sclerosis Complex (TSC): 3-Year Results From GWPCARE6 Open-Label Extension (OLE)

              Author:Thiele, Elizabeth   Bebin, E. Martina   Filloux, Francis   Jansen, Floor   Kwan, Patrick   Loftus, Rachael   Sahebkar, Farhad   Sparagana, Steven   lawson, John   Wheless, James   

              Session Name:P14: Epilepsy/Clinical Neurophysiology (EEG): ASMs Clinical Trial 2  

              Topic:Epilepsy/Clinical Neurophysiology (EEG)  

              Program Number:P14.004  

              Author Institution:Massachusetts General Hospital, Boston, MA  University of Alabama School of Medicine, Birmingham, AL  University of Utah School of Medicine, Salt Lake City, UT  Brain Center University Medical Center, Utrecht, Netherlands  Monash University and the University of Melbourne, Melbourne, Australia  Jazz Pharmaceuticals, Inc., Cambridge, United Kingdom  Jazz Pharmaceuticals, Inc., Carlsbad, CA  Scottish Rite for Children and the University of Texas Southwestern Medical Center, Dallas, TX  Sydney Children’s Hospital, Randwick, Australia  UTHSC-Pediatric Neurology, Memphis, TN  

              Predictors of Sustainability of Response With Cenobamate: Post-hoc Subset Analysis of a Phase 3, Open-Label, Study

              Author:Stern, MS, Sean   Wechsler, MD, PhD, Robert   Kerr, MD, PhD, Wesley T.   Wade, MBA, Clarence T.   Vossler, MD, David G.   Rosenfeld, MD, William E.   

              Session Name:P14: Epilepsy/Clinical Neurophysiology (EEG): ASMs Clinical Trial 2  

              Topic:Epilepsy/Clinical Neurophysiology (EEG)  

              Program Number:P14.005  

              Author Institution:SK Life Science, Inc., Paramus, NJ, USA, Paramus, NJ  Consultants in Epilepsy & Neurology and Idaho Comprehensive Epilepsy Center, Boise, ID, USA, Boise, ID  Department of Neurology, University of Michigan, Ann Arbor, MI, USA, Ann Arbor, MI  University of Washington School of Medicine, Seattle, WA, USA, Renton, WA  Comprehensive Epilepsy Care Center for Children and Adults, St. Louis, MO, USA, St. Louis, MO